4 research outputs found

    Study on the Border Effect of Taiwan Strait towards the Cross-Strait Communication and Interaction Standardization

    Get PDF
    随着海峡两岸"大三通"的启动,《海峡两岸标准计量检验认证合作协议》的签署,两岸经贸往来快速发展,标准化交流合作不断深化。本文首先基于2002-2012年中国大陆31个省份与台湾省的有效标准数量,使用双倍差分法,对两岸标准化交流互动是否存在边界效应进行了检验。验证结果表明,在2008年"大三通"之后,台湾的标准化进程对边界地区影响大于非边界地区,存在即刻和滞后一年的边界效应。其次,以农业和物流业为例,从偏好,公共部门的政策,制度,信息成本,基础设施成本和偏好5个方面分析两岸标准化交流互动边界效应的影响机制。最后,提出促进两岸标准化交流互动的政策建议。Since the start-up of "three direct links", direct flights, shipping and postal services between Taiwan and the mainland, and the signature of Cross-Strait Standard Measurement Examination and Certification Cooperation Agreement, economic and trade contact has developed rapidly, and standardization communication and cooperation has constantly deepened. This article, firstly, tests the border effect of standard communication and cooperation of the mainland and Taiwan based on the data of valid standard quantity of the 31 provinces in mainland and Taiwan with the method of the double difference model. The result implies that since "three direct links" in 2008, the standardization process of Taiwan has a greater influence of an immediate and one-year-lagged border effect on the border regions than the non-border regions in mainland. Secondly, taking the case of agriculture and logistics for example, it analyzes how the border effect works from five perspectives including public policy, system, information cost, infrastructure cost and preference. Finally, it puts forward some policy proposals for promoting the communication and interaction of cross-strait standardization.国家质量监督检验检疫总局科技计划项目“台海对两岸标准交流互动的边界效应研究”(项目编号:T2015-FJQTS-0019)的研究成

    过滤、吸附及灭活病毒的纳米催化材料的快速筛选方法

    No full text
    本发明涉及催化材料,具体地说是一种过滤、吸附及灭活病毒的纳米催化材料的快速筛选方法,具体操作为:1)以100~1000个碱基的核酸分子片段作为探针,采用喷洒或浸泡的方式将核酸分子吸附于催化剂上,然后用不少于探针原液9倍的水进行洗脱,筛选出吸附能力强的、即吸附量为原液重量60%)以上的催化剂;2)将上述步骤选取的催化剂对目标病毒进行吸附、洗脱,对催化剂用水或生理盐水一次或多次洗脱,然后对洗脱液中的病毒进行传统的活性检测;筛选出对病毒的过滤、吸附及灭活作用好的、即吸附量为原液重量95%的催化剂。本发明首先以核酸分子作为探针,建立了对纳米催化材料吸附性能和抗水性能进行快速筛选和评价的方法。带填

    Ziprasidone versus other atypical antipsychotics for schizophrenia

    No full text
    corecore